OMEICOS Therapeutics

OverviewSuggest Edit

OMEICOS Therapeutics develops therapeutics for the prevention and treatment of cardiovascular diseases. It also offers its therapeutic services for the treatment in inflammatory, cardiovascular, ophthalmology, and other disease indications. Its therapeutic strategy is based upon the discovery of natural CYP-P450 generated metabolites of omega-3 fatty acids, so called epoxyeicosanoids. This new class of bioactive lipid mediators activates type specific cellular endogenous pathways that can be therapeutically deployed in inflammatory, cardiovascular, and other diseases.

TypePrivate
Founded2013
HQBerlin, DE
Websiteomeicos.com

Recent NewsAll News

Latest Updates

Employees (est.) (Aug 2020)16(-11%)
Cybersecurity ratingAMore

Key People/Management at OMEICOS Therapeutics

Robert Fischer

Robert Fischer

Co-founder and CEO/CSO
Luciana Summo

Luciana Summo

Director Clinical Operations
Simon Russell

Simon Russell

CBO
Show more

OMEICOS Therapeutics Office Locations

OMEICOS Therapeutics has offices in Berlin and Cambridge
Berlin, DE (HQ)
10 Robert-Rössle-Straße
Cambridge, US
1 Broadway
Show all (2)

OMEICOS Therapeutics Financials and Metrics

Summary Metrics

OMEICOS Therapeutics's latest funding round in November 2018 was reported to be $19.3 m. In total, OMEICOS Therapeutics has raised $36.6 m
Show all financial metrics

OMEICOS Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

OMEICOS Therapeutics Online and Social Media Presence

Embed Graph

OMEICOS Therapeutics Blogs

ESC Congress 2019 together with World Congress of Cardiology

Meet us at ESC Congress, August 31 – September 4, 2019 in Paris in one-to-one meetings as well as for informal networking. https://www.escardio.org/Congresses-&-Events/ESC-Congress

Markus Henrich

Consultant Medicinal Chemistry and CMC(HENRICH Life Science R&D Consulting) Markus Henrich has more than 20 years of experience in various roles in the pharmaceutical industry, amongst them Executive Director Drug Discovery and Development at Merz Pharmaceuticals GmbH. In his current role as Man…
Show more

OMEICOS Therapeutics Frequently Asked Questions

  • When was OMEICOS Therapeutics founded?

    OMEICOS Therapeutics was founded in 2013.

  • Who are OMEICOS Therapeutics key executives?

    OMEICOS Therapeutics's key executives are Robert Fischer, Luciana Summo and Simon Russell.

  • How many employees does OMEICOS Therapeutics have?

    OMEICOS Therapeutics has 16 employees.

  • Who are OMEICOS Therapeutics competitors?

    Competitors of OMEICOS Therapeutics include Alimera Sciences, Biogen and MyoKardia.

  • Where is OMEICOS Therapeutics headquarters?

    OMEICOS Therapeutics headquarters is located at 10 Robert-Rössle-Straße, Berlin.

  • Where are OMEICOS Therapeutics offices?

    OMEICOS Therapeutics has offices in Berlin and Cambridge.

  • How many offices does OMEICOS Therapeutics have?

    OMEICOS Therapeutics has 2 offices.